Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-β

Cytokine

Volumn 47, Issue 3, 2009, Pages 199-205

  Bartee, Eric ^a   McFadden, Grant ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Cytostasis; IFN; Synergy; TNF

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER CELL; CELL IMMORTALIZATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOSTASIS; DNA SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELLS, CULTURED; CYTOSTATIC AGENTS; DRUG SYNERGISM; HUMANS; INTERFERON-BETA; KINETICS; MYXOMA VIRUS; ONCOLYTIC VIRUSES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 68949163770     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.06.006     Document Type: Article

References (16)

1. Remick D., and Friedland J. Cytokines in health and disease (1997), Marcel Dekker, Inc., New York, NY
2. Weinberg R. The Biology of Cancer: Garland Science; 2007.
3. Kerr P., and McFadden G. Immune responses to myxoma virus. Viral Immunol 15 (2002) 229-246
4. Stanford M.M., Werden S.J., and McFadden G. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host. Vet Res 38 (2007) 299-318
5. Fenner F., Poole W.E., Marshall I.D., and Dyce A.L. Studies in the epidemiology of infectious myxomatosis of rabbits. VI. The experimental introduction of the European strain of myxoma virus into Australian wild rabbit populations. J Hyg (Lond) 55 (1957) 192-206
6. Stanford M.M., and McFadden G. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Expert Opin Biol Ther 7 (2007) 1415-1425
7. Wang F., Gao X., Barrett J.W., Shao Q., Bartee E., Mohamed M.R., et al. RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. PLoS Pathog 4 (2008) e1000099
8. Bartee E., Mohamed M.R., Lopez M.C., Baker H., and McFadden G. Addition of TNF plus IFN-{beta} induces a novel synergistic anti-viral state against poxviruses in primary human fibroblasts. J Virol 83 (2008) 498-511
9. Johnston J.B., Barrett J.W., Chang W., Chung C.S., Zeng W., Masters J., et al. Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J Virol 77 (2003) 5877-5888
10. Yarilina A., Park-Min K.H., Antoniv T., Hu X., and Ivashkiv L.B. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 9 (2008) 378-387
11. Reis L.F., Ho Lee T., and Vilcek J. Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts. J Biol Chem 264 (1989) 16351-16354
12. Schijns V.E., Van der Neut R., Haagmans B.L., Bar D.R., Schellekens H., and Horzinek M.C. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells. J Gen Virol 72 Pt. 4 (1991) 809-815
13. Bartee E., Mohamed M.R., and McFadden G. Tumor necrosis factor and interferon: cytokines in harmony. Curr Opin Microbiol 11 (2008) 378-383
14. Watanabe N., Niitsu Y., Yamauchi N., Umeno H., Sone H., Neda H., et al. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r. J Biol Response Mod 7 (1988) 24-31
15. Sainz Jr. B., and Halford W.P. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J Virol 76 (2002) 11541-11550
16. Yao Q., Qian P., Cao Y., He Y., Si Y., Xu Z., et al. Synergistic inhibition of pseudorabies virus replication by porcine alpha/beta interferon and gamma interferon in vitro. Eur Cytokine Netw 18 (2007) 71-77